Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
Published on: February 9, 2024
Tracing the molecular route to progression in miRNA-biogenesis-defective thyroid lesions
Anne-Sophie Chong1,2, Carla Roca1,3, Paula Morales-Sánchez3
1Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Abstract:
Germline and somatic changes in DICER1 and DGCR8 microprocessors confer risk of developing benign and malignant thyroid lesions, yet the molecular events driving malignant transformation remain unclear. We trace the molecular trajectories from benignity to malignancy in DICER1- and DGCR8-mutated thyroid lesions using multiomic profiling on over 30 DICER1-/DGCR8-mutated samples. Our findings reveal a progressive, specific, and linear accumulation of genetic changes, which when combined with enhanced downregulation of miRNAs distinguished DICER1-/DGCR8-malignant lesions from their benign counterparts. Compensatory hypomethylation of miRNA-encoding genes characterized DICER1-/DGCR8-benign lesions, but as the tumors progressed to malignancy, methylation was partly reimposed, reversing the attempts to activate miRNA-encoded genes and further compromising miRNA production. Transcriptomic analyses revealed mutation-specific effects on the microenvironment, whereby DICER1 mutations activated canonical thyroid cancer progression pathways, whereas altered DGCR8 associated with immune-related changes. This work unveils specific molecular events underlying malignant progression of miRNA-biogenesis-related thyroid tumors and identifies potential biomarkers and disease etiology mechanisms.
Insights
Genetic changes in DICER1 and DGCR8 microprocessors drive thyroid tumor progression. Malignant transformation involves specific genetic accumulation and miRNA downregulation, with distinct microenvironment impacts.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Germline and somatic mutations in DICER1 and DGCR8 are linked to thyroid lesions.
- The molecular mechanisms driving malignant transformation in these tumors are not fully understood.
Purpose of the Study:
- To investigate the molecular trajectories from benign to malignant thyroid lesions with DICER1 and DGCR8 mutations.
- To identify key molecular events and pathways involved in malignant progression.
Main Methods:
- Multiomic profiling of over 30 DICER1/DGCR8-mutated thyroid samples.
- Analysis of genetic alterations, miRNA expression, DNA methylation, and transcriptomics.
Main Results:
- A progressive, linear accumulation of genetic changes distinguishes malignant from benign lesions.
- Enhanced miRNA downregulation and altered DNA methylation patterns characterize malignant transformation.
- DICER1 mutations activate thyroid cancer pathways, while DGCR8 alterations are associated with immune changes in the tumor microenvironment.
Conclusions:
- Specific molecular events drive the malignant progression of miRNA-biogenesis-related thyroid tumors.
- Findings identify potential biomarkers and mechanisms for disease etiology.
Related Concept Videos
Routes of Persuasion
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Lumber Defects
Shakes are minor fractures that run along or across the wood's annual rings, while wane is...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Molecular Models

